Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(4 sites)
United States
National Institute of Health, Bethesda, Maryland Lahey Hospital & Medical Center, Burlington, Massachusetts Mount Sinai Hospital, New York, New York Last updated February 2026